Marcos F. Fondevila
Santiago De Compostela, GA 15782, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Non-absorbable antibiotics worsen alcohol-associated liver disease in gastric acid-suppressed mice.
Journal: Gut microbes
Published: July 09, 2026
Targeting microbial bile salt hydrolase reprograms bile acid metabolism and ameliorates metabolic dysfunction-associated steatohepatitis in mice.
Journal: Molecular metabolism
Published: June 01, 2026
Targeting Microbial Bile Salt Hydrolase Reprograms Bile Acid Metabolism and Ameliorates Metabolic Dysfunction-Associated Steatohepatitis in Mice.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
Reply to: "Hepatic CTSB is Kupffer cell-enriched, whereas disease-state stratification is more strongly captured by endotoxin/TLR4 programmes".
Journal: Journal of hepatology
Published: April 23, 2026
Faecal Cathepsin B and S Are Associated With Liver Disease Severity and Adiposity in MASLD.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 01, 2026
Parallel regulation of goblet cell-associated antigen passages by reduced microbial sensing and mAChR4 signaling in Muc2 deficiency prevents ethanol-induced liver injury.
Journal: Hepatology (Baltimore, Md.)
Published: September 17, 2025
Macrophage-derived cathepsin B disrupts intestinal tight junctions through occludin degradation and promotes alcohol-associated liver disease.
Journal: Journal of hepatology
Published: July 18, 2025
Macrophage-derived cathepsin B disrupts intestinal tight junctions through occludin degradation and promotes alcohol-associated liver disease.
Journal: Journal of hepatology
Published: July 18, 2025
Peptide YY reduces cytotoxicity of Candida albicans in alcohol-associated liver disease.
Journal: JHEP reports : innovation in hepatology
Published: April 15, 2025
Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease.
Journal: The Journal of clinical investigation
Published: October 31, 2024
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease.
Journal: Cell host & microbe
Published: September 29, 2024
Last Updated: 09/26/2026